Active-ingredient Dossier
Ethinylestradiol
Active-ingredient Dossier for Ethinylestradiol (combined oral contraceptive). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: NUVARING
- Brand: ROSIE
- Brand: YASMIN
- Brand: SEASONIQUE
- Brand: BROOKE
- Brand: BROOKLYNN
- Therapeutic area: Reproductive Health
What is
Ethinylestradiol Ethinylestradiol is a combined oral contraceptive.
Therapeutic areas
Ethinylestradiol is registered in reproductive health (40 brands), women's health (4 brands), oncology (3 brands), and dermatology (2 brands).
Sponsor landscape
Ethinylestradiol is marketed by Arrotex Pharmaceuticals, Bayer, Pfizer, Lupin, Strides Pharma Science, and Maple Healthcare.
PBS and regulatory activity
Three brands containing ethinylestradiol have PBAC outcomes on record, with the latest outcome dated 1 May 2025. One brand has an AusPAR on record, dated 23 May 2016.